Context Therapeutics (CNTX) Interest Expenses (2020 - 2026)

Context Therapeutics (CNTX) posted Interest Expenses of $9.5 million for Q1 2026, up 221.89% sequentially from $2.9 million in Q4 2025.

Context Therapeutics (CNTX) Interest Expenses (2020 - 2026) Analysis & Trends

Context Therapeutics has reported Interest Expenses for 7 years, with the latest figure at $9.5 million in Q1 2026.

Quarterly Interest Expenses changed N/A year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (changed N/A YoY) and the FY2025 annual result came in at $35.9 million, up 45.0% from the prior year.
Interest Expenses advanced to $9.5 million in Q1 2026 per CNTX's latest filing, from $2.9 million in the prior quarter.
Over five years, Interest Expenses peaked at $24.8 million in Q4 2024 and troughed at $2116.0 in Q2 2025.
A 5-year average of $5.7 million and a median of $1.8 million in 2024 frame the typical range for Interest Expenses.
The sharpest annual moves came in 2022 and 2025: Interest Expenses jumped 39864.09% in 2022, then tumbled 99.88% in 2025.
Over 5 years, Interest Expenses stood at $9.2 million in 2022, then surged by 80.65% to $16.6 million in 2023, then soared by 49.11% to $24.8 million in 2024, then sank by 88.12% to $2.9 million in 2025, then jumped by 221.89% to $9.5 million in 2026.
According to Business Quant data, Interest Expenses over the past three periods registered $9.5 million, $2.9 million, and $712194.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	11.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	39.74 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	82.05 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-4.89 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	20.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	93.62 Mn
10	Context Therapeutics	48.18 Mn	48.18 Mn	-	-

Download Data